MedPath

A Clinical trial to study the effect of Kalingathi ennai in the patients having Polycystic Ovarian syndrome

Phase 2
Recruiting
Conditions
SOOTHAGAVAAYU (POLYCYSTIC OVARIAN SYNDROME)
Registration Number
CTRI/2018/03/012768
Lead Sponsor
Government Siddha Medical College
Brief Summary

This is a single Non randomized open clinical trial to study the safety and efficacy of Siddha trial drug Kalingathi ennai. The trial drug is given 15ml once a day for 5 days for three consecutive cycles. Clinical trial is conducted after conducting Preclinical toxicity study. The trial drug Kalingathi ennai is mentioned in Sikitcha ratna deepam .During the trial all the study related data will be recorded and documented. After the completion of trial all the data will be analysed statistically.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Female
Target Recruitment
40
Inclusion Criteria

1 Married/unmarried 2 Irregular menstruation 3 Oligomenorrhoea 4 Dysmenorrhoea 5 Ovulation related infertility 6 Polycystic ovary in ultra sound.

Exclusion Criteria

1 Hyperthyroidism/hypothyroidism 2 Congenital uterine defects 3 Endometriosis 4 Tuberculosis of the ovary and uterus 5 Pituitary/ adrenal disorders 6 Hemorrhagic cyst 7 Chocolate cyst.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome is mainly assessed by reduction in clinical symptoms i.e, changes in the hormonal profile and changes in the size of the cyst5 Days for three consecutive cycles
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aringar Anna Government hospital of Indian Medicine

🇮🇳

Chennai, TAMIL NADU, India

Aringar Anna Government hospital of Indian Medicine
🇮🇳Chennai, TAMIL NADU, India
Dr Brunda S
Principal investigator
8608931558
drsbrinda92@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.